{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:44:26Z","timestamp":1788813866282,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejso.2026.111393","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:44:45Z","timestamp":1768376685000},"page":"111393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeted axillary dissection after neoadjuvant chemotherapy in breast cancer patients with a high lymph node burden: Radiological and histological outcomes"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7333-2730","authenticated-orcid":false,"given":"A.","family":"Nanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7306-7140","authenticated-orcid":false,"given":"M.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Alaradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Merh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Sinnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Krupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K.","family":"Tasoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0967-1778","authenticated-orcid":false,"given":"J.E.","family":"Rusby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5990-8142","authenticated-orcid":false,"given":"R.L.","family":"O'Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.111393_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.amjsurg.2022.11.036","article-title":"Contemporary approaches to the axilla in breast cancer","volume":"225","author":"Thompson","year":"2023","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2026.111393_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/j.seminoncol.2020.09.001","article-title":"Axillary surgery in breast cancer: an updated historical perspective","volume":"47","author":"Magnoni","year":"2020","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejso.2026.111393_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2026.111393_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2015.02.011","article-title":"Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the national cancer database","volume":"220","author":"Killelea","year":"2015","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejso.2026.111393_bib5","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"For the A. for C.T. in oncology, sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2026.111393_bib6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.111393_bib7","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1245\/s10434-019-07809-7","article-title":"Axillary lymph node ultrasound following neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: results from the SN FNAC study","volume":"26","author":"Morency","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111393_bib8","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111393_bib9","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1186\/s12885-024-13001-2","article-title":"Targeted axillary dissection using carbon marking for patients with node-positive breast cancer following neoadjuvant therapy (TADCOM): study protocol for a prospective, multicenter, randomized controlled trial","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2026.111393_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111393_bib11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ejso.2022.12.019","article-title":"Clinical utility of axillary nodal markers in breast cancer","volume":"49","author":"Barry","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111393_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamasurg.2023.1772","article-title":"Safety of targeted axillary dissection after neoadjuvant therapy in patients with node-positive breast cancer","volume":"158","author":"Kuemmel","year":"2023","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2026.111393_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/bjs\/znac413","article-title":"Long-term survival in patients with node-positive breast cancer who undergo sentinel lymph node biopsy alone after neoadjuvant chemotherapy: meta-analysis","volume":"110","author":"Keelan","year":"2023","journal-title":"BJS"},{"key":"10.1016\/j.ejso.2026.111393_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jamaoncol.2024.0578","article-title":"Omission of axillary dissection following nodal downstaging with neoadjuvant chemotherapy","volume":"10","author":"Montagna","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2026.111393_bib15","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1200\/JCO.23.00435","article-title":"Standardized definitions for efficacy end points in neoadjuvant breast cancer clinical trials: NeoSTEEP","volume":"41","author":"Litton","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111393_bib16","series-title":"Ann surg","first-page":"608","article-title":"Tumor biology correlates with rates of breastconserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer findings from the ACOSOG Z1071 (alliance) prospective multicenter clinical trial","author":"Boughey","year":"2014"},{"key":"10.1016\/j.ejso.2026.111393_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jss.2020.12.007","article-title":"Impact of breast cancer pretreatment nodal burden and disease subtype on axillary surgical management","volume":"261","author":"Ng","year":"2021","journal-title":"J Surg Res"},{"key":"10.1016\/j.ejso.2026.111393_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/bjs.4010","article-title":"Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer","volume":"90","author":"Voogd","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2026.111393_bib19","article-title":"Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer","author":"Weber","year":"2018","journal-title":"TAXIS) (TAXIS)"},{"key":"10.1016\/j.ejso.2026.111393_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104411","article-title":"Omitting axillary lymph node dissection in breast cancer patients with extensive nodal disease and excellent response to primary systemic therapy using the MARI protocol","volume":"80","author":"van Hemert","year":"2025","journal-title":"Breast"},{"key":"10.1016\/j.ejso.2026.111393_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.breast.2017.05.015","article-title":"The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT)","volume":"35","author":"Peppe","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.ejso.2026.111393_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115607","article-title":"Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients \u2013 results from the prospective AXSANA registry trial","volume":"226","author":"Di Micco","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2026.111393_bib23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s00330-023-10155-8","article-title":"Diagnostic performance of MRI for assessing axillary lymph node status after neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis","volume":"34","author":"Li","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2026.111393_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-013-2678-8","article-title":"Pre-chemotherapy 18F-FDG PET\/CT upstages nodal stage in stage II\u2013III breast cancer patients treated with neoadjuvant chemotherapy","volume":"141","author":"Koolen","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2026.111393_bib25","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.2147\/CMAR.S244806","article-title":"Accuracy of sentinel lymph node biopsy in breast cancer: pitfalls in the application of single tracers","volume":"12","author":"Yang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ejso.2026.111393_bib26","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1002\/cncr.25066","article-title":"Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment","volume":"116","author":"Brown","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2026.111393_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108340","article-title":"Application value of a hybrid tracer during sentinel lymph node biopsy for head and neck malignancies: a systematic review and meta-analysis","volume":"50","author":"Wang","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111393_bib28","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1245\/s10434-024-15292-y","article-title":"Oncologic outcomes for different axillary staging techniques in patients with nodal-positive breast cancer undergoing neoadjuvant systematic treatment: a cancer registry study","volume":"31","author":"Pfob","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111393_bib29","doi-asserted-by":"crossref","first-page":"8813","DOI":"10.1245\/s10434-024-16143-6","article-title":"Omission of axillary lymph node dissection in patients with residual nodal disease after neoadjuvant chemotherapy","volume":"31","author":"Limberg","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111393_bib30","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1245\/s10434-024-16382-7","article-title":"Significance of residual nodal disease in clinically node-negative breast cancer after neoadjuvant chemotherapy","volume":"32","author":"So","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111393_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108245","article-title":"Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry","volume":"50","author":"Loveland-Jones","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111393_bib32","series-title":"Comparison of axillary lymph node dissection with axillary radiation for patients with node-positive breast cancer treated with chemotherapy A011202","article-title":"Alliance for clinical trials in oncology (responsible party)","author":"Bougher","year":"2025"},{"key":"10.1016\/j.ejso.2026.111393_bib33","article-title":"ATNEC: a multicenter, randomized trial investigating whether axillary treatment can be avoided in patients with T1-3N1M0 breast cancer with no residual cancer in the lymph glands after neoadjuvant chemotherapy","volume":"40","author":"Goyal","year":"2025","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:51:49Z","timestamp":1775602309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0748798326000120"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111393","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted axillary dissection after neoadjuvant chemotherapy in breast cancer patients with a high lymph node burden: Radiological and histological outcomes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111393"}}